PEPGEN INC. Increase (Decrease) in Prepaid Expenses, Other
PEPGEN INC. (PEPG) reported Increase (Decrease) in Prepaid Expenses, Other of $217.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-06
- PEPGEN INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was $755.00K.
- PEPGEN INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was -$538.00K.
- PEPGEN INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was -$46.00K, a 174.19% decline year-over-year.
- PEPGEN INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was -$291.00K, a 865.79% decline year-over-year.
- PEPGEN INC. increase (decrease) in prepaid expenses, other for fiscal 2025 was -$1.07M, a 182.55% decline from fiscal 2024.
- PEPGEN INC. increase (decrease) in prepaid expenses, other for fiscal 2024 was $1.30M.
- PEPGEN INC. increase (decrease) in prepaid expenses, other for fiscal 2023 was -$2.06M, a 215.70% decline from fiscal 2022.
- PEPGEN INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was $1.78M, a 19.46% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 6 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 9 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 12 month | Increase (Decrease) in Prepaid Expenses, Other 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $755.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $217.00K 10-Q · filed 2026-08-06 | $171.00K derived: sum of 3 quarters · filed 2026-08-06 | -$120.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$538.00K 10-Q · filed 2026-05-12 | -$584.00K derived: sum of 2 quarters · filed 2026-05-12 | -$875.00K derived: sum of 3 quarters · filed 2026-05-12 | -$1.31M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$337.00K derived: sum of 2 quarters · filed 2026-03-04 | -$770.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.07M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | -$291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$724.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.03M 10-Q · filed 2025-11-12 | -$966.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$433.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$737.00K 10-Q · filed 2026-08-06 | -$675.00K derived: sum of 3 quarters · filed 2026-08-06 | -$637.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$304.00K 10-Q · filed 2026-05-12 | -$242.00K derived: sum of 2 quarters · filed 2026-05-12 | -$204.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.06M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $100.00K derived: sum of 2 quarters · filed 2026-03-04 | $1.36M derived: sum of 3 quarters · filed 2026-03-04 | $1.30M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.30M derived: sum of 2 quarters · filed 2025-11-12 | $1.24M 10-Q · filed 2025-11-12 | -$68.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.20M 10-Q · filed 2025-08-07 | -$106.00K derived: sum of 3 quarters · filed 2025-08-07 | -$46.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | -$62.00K 10-Q · filed 2025-05-08 | -$1.37M derived: sum of 2 quarters · filed 2025-05-08 | -$1.31M derived: sum of 3 quarters · filed 2025-05-08 | -$859.00K derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | -$1.25M derived: sum of 2 quarters · filed 2025-02-24 | -$797.00K derived: sum of 3 quarters · filed 2025-02-24 | -$2.06M 10-K · filed 2025-02-24 | -$2.04M 10-K · filed 2024-03-06 | ||
| 2023-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $510.00K derived: sum of 2 quarters · filed 2024-11-07 | -$757.00K 10-Q · filed 2024-11-07 | -$732.00K 10-Q · filed 2023-11-08 | $148.00K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$817.00K 10-Q · filed 2024-08-08 | -$609.00K 10-Q · filed 2023-08-08 | $88.00K derived: sum of 3 quarters · filed 2024-08-08 | $41.00K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$1.27M 10-Q · filed 2024-05-14 | -$362.00K derived: sum of 2 quarters · filed 2024-05-14 | -$409.00K derived: sum of 3 quarters · filed 2024-05-14 | $799.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $905.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-29 | $858.00K derived: sum of 2 quarters · filed 2024-03-29 | $2.07M derived: sum of 3 quarters · filed 2024-03-29 | $1.78M 10-K/A · filed 2024-03-29 | |||
| 2022-09-30 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.16M derived: sum of 2 quarters · filed 2023-11-08 | $879.00K 10-Q · filed 2023-11-08 | $1.73M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $926.00K 10-Q · filed 2023-08-08 | $1.78M derived: sum of 3 quarters · filed 2023-08-08 | $1.45M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | -$282.00K 10-Q · filed 2023-05-11 | $569.00K derived: sum of 2 quarters · filed 2023-05-11 | $243.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.58M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $851.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $525.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.86M derived: sum of 3 quarters · filed 2023-03-23 | $2.21M 10-K · filed 2023-03-23 | |||
| 2021-09-30 | -$326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.01M derived: sum of 2 quarters · filed 2022-11-10 | $1.36M 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.69M 10-Q · filed 2022-08-12 | |||||
| 2021-03-31 | $351.00K 10-Q · filed 2022-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |